CSGALNACT1 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5113845-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA5113845 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
CSGALNACT1
Classification
Polyclonal
Conjugate
Unconjugated
Gene
CSGALNACT1
Gene Alias
4732435N03Rik; beta1,4 N-acetylgalactosaminyltransferase; beta4GalNAcT; Beta4GalNAcT-1; Chgn; chondroitin beta1,4 N-acetylgalactosaminyltransferase; Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1; chondroitin sulfate N-acetylgalactosaminyltransferase 1; CSGALNACT1; CsGalNAcT-1; Galnact1; glucuronylgalactosylproteoglycan 4-beta-N- acetylgalactosaminyltransferase; RGD1307618; UNQ656/PRO1287
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
55790
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
Western Blot
Concentration
0.5 mg/mL
Formulation
PBS with 2% sucrose and 0.09% sodium azide
Gene Accession No.
Q8TDX6
Gene Symbols
CSGALNACT1
Immunogen
Synthetic peptide directed towards the C terminal region of human ChGn
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Immunogen sequence: DELTPEQYKM CMQSKAMNEA SHGQLGMLVF RHEIEAHLRK QKQKTSSKKT For short term use, store at 2-8°C up to 1 week
- For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles
- Predicted homology: Cow: 79%; Dog: 100%; Guinea Pig: 100%; Horse: 100%; Human: 100%; Mouse: 100%; Rabbit: 93%; Rat: 100%; Zebrafish: 100% CSGALNACT1 transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA)
- CSGALNACT1 required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains
- CSGALNACT1 is important role in chondroitin chain biosynthesis in cartilage.